Reverence For Life

The legislative session ends next Friday, and we will see a flurry of activity at the Capitol this coming week as bills are either passed and sent to the Governor or meet their end for this round.

On Monday, SB 380 (Eggman – D, Stockton), the physician-assisted suicide expansion bill, passed out of the Assembly Judiciary Committee on a 6 – Yes, 2 – No, and 3 – Abstain vote.

This week, representatives from the California Catholic Conference testified at a hearing of the Committee on the Revision of the Penal Code, supporting the Committee's May 2021 recommendation that the death penalty be abolished.

Despite the large number of those who wrote to their lawmakers, the State Assembly Health Committee voted to pass SB 380, the bill intended to remove "safeguards" from the physician-assisted suicide law passed in 2015.

For 45 years, the Hyde amendment has protected taxpayers from being forced to pay for elective abortions.

The CCC is disappointed to report that SB 380, the bill extending physician-assisted suicide, p

For the first time in 45 years, a U.S. president has released a budget proposal that excludes the Hyde Amendment, which prohibits federal funds in Medicaid and other programs from paying for abortions.

Physician-assisted suicide is sadly legal in California through the so-called End of Life Option Act, which narrowly passed in 2015 with “safeguards” to ensure the law wasn’t inappropriately used. Now, lawmakers are trying to remove those “safeguards,” absurdly arguing that those measures prohibit too many people from using the method.

Assisted suicide is already legal in California through the so-called End of Life Option Act, narrowly passed by the California Legislature and signed by then-Gov. Jerry Brown in 2015. The bill received opposition from both Democrat and Republican Assembly members and state senators but was passed, many feel inappropriately, during a Special Legislative Session focused on Medi-Cal funding.

The USCCB's response to the National Institute of Health is reversing limits on human fetal tissue research.